Memphis Pharmaceuticals & Chemical Industries

CASE:MPCI Stock Report

Market Cap: ج.م296.8m

Memphis Pharmaceuticals & Chemical Industries Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bassem Abdullah

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure4.5yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

CEO

Bassem Abdullah

3.4yrs

Tenure

Dr. Bassem Muhammad Abdullah is CEO, Executive MD & Director of Memphis Pharmaceuticals & Chemical Industries from August 2021.

Leadership Team

NamePositionTenureCompensationOwnership
Bassem Abdullah
CEO, Executive MD & Director3.4yrsno datano data
Walid Hassan
Head of the Financial Sector5yrsno datano data
Abdul Hakim Farouk Aziz
Head of Administrative Affairs & HR4.5yrsno datano data
Asem Ibrahim
Head of Legal Affairs Sectorno datano datano data
Ahmed Hamed Khalil
Head of Production Sectorno datano datano data
Ashrf Slim
Head of the Engineering Sectorno datano datano data
Yasser Gendy
Head of Warehouse & Procurement Sectorno datano datano data
Abeer Fahmy
Head of Quality Assurance & Internal Auditing Sector4.5yrsno datano data
Maysara Zain Al Abidine
Head of Planning & Information Systems Sector4.5yrsno datano data
Salwa Abdel Hafeez Mahmoud
Head of Research & Supervision Sector5yrsno datano data

4.5yrs

Average Tenure

Experienced Management: MPCI's management team is considered experienced (4.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Bassem Abdullah
CEO, Executive MD & Director3.4yrsno datano data
Essam Muhammad
Non-Executive Chairman3.6yrsno datano data
Reda Al-Sayed
Directorno datano datano data
Amani Kamel
Independent Directorno datano datano data
Tariq Salman
Director3yrsno datano data
Miral Abdel Darwish
Directorno datano datano data

3.4yrs

Average Tenure

Experienced Board: MPCI's board of directors are considered experienced (3.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:58
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Memphis Pharmaceuticals & Chemical Industries is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution